Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital's purchase of Asembia may ...

Pharmacy is a highly litigated corner of healthcare, with major fights running on four separate tracks: state laws banning PBMs from owning pharmacies, drugmakers challenging state 340B protections, ...

Craneware’s 340B revenue slips in the final weeks of its financial year have pushed the AIM-listed healthcare software ...

The bill would increase the "dispensing fee" that pharmacy benefit managers have to pay to pharmacies. But who would shoulder ...

Ozempic lists for roughly $969 in the United States and around €59 in Germany — the same pen, the same molecule, made in the same Danish factory. The reason winds back to a Nobel laureate's 1922 trip ...

Texas lawmakers are right to ask why health care keeps getting more expensive.Texas Speaker Dustin Burrows created the House ...

A group representing thousands of pharmacies has filed an antitrust suit against Prime Therapeutics, alleging that the company colluded with rival Express Scripts to fix prices. The lawsuit was filed ...

Nearly 5,000 independent pharmacies have filed an antitrust and breach-of-contract lawsuit against Prime Therapeutics, LLC, ...

There have been two major recent developments in the ongoing national struggle over the state regulation of pharmacy benefit managers (PBMs).

A pharmacy survey found most UK pharmacists expect fake Wegovy tablets to enter the illegal market as demand for the new weight-loss pill grows.